Citigroup’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.9M | Sell |
|
|||||
|
2025
Q1 | $48.5M | Sell |
|
|||||
|
2024
Q4 | $42.2M | Buy |
|
|||||
|
2024
Q3 | $39.2M | Buy |
|
|||||
|
2024
Q2 | $33.3M | Sell |
|
|||||
|
2024
Q1 | $55.3M | Buy |
|
|||||
|
2023
Q4 | $62.9M | Sell |
|
|||||
|
2023
Q3 | $41.9M | Buy |
|
|||||
|
2023
Q2 | $24.6M | Sell |
|
|||||
|
2023
Q1 | $25.7M | Buy |
|
|||||
|
2022
Q4 | $10.6M | Sell |
|
|||||
|
2022
Q3 | $15.1M | Buy |
|
|||||
|
2022
Q2 | $13.4M | Buy |
|
|||||
|
2022
Q1 | $11.5M | Sell |
|
|||||
|
2021
Q4 | $20.2M | Buy |
|
|||||
|
2021
Q3 | $22.4M | Sell |
|
|||||
|
2021
Q2 | $38.4M | Buy |
|
|||||
|
2021
Q1 | $37.2M | Buy |
|
|||||
|
2020
Q4 | $38.4M | Sell |
|
|||||
|
2020
Q3 | $27.3M | Sell |
|
|||||
|
2020
Q2 | $26.4M | Buy |
|
|||||
|
2020
Q1 | $3.39M | Buy |
|
|||||
|
2019
Q4 | $874K | Buy |
|
|||||
|
2019
Q3 | $21K | Buy |
|